EGFR and urinary bladder carcinoma: Promotion: Studies show that ARs increase the protein level and activity of the epidermal growth factor receptor (EGFR) as well as Herb2, promoting the development and progression of bladder cancer through the EGFR / ERBB2 pathway [46].